This study demonstrates that the levels of gB-specific IgG and IgA in vaginal washes of mice immunized intranasally (i.n.) with a recombinant adenovirus vector expressing herpes simplex virus (HSV) glycoprotein B (AdgB8) vary inversely with each other and are dependent on the stage of the estrous cycle. Anti-gB IgA titers in vaginal washes were significantly higher during estrus than diestrus or proestrus, whereas specific IgG titers were significantly higher during diestrus than estrus. This was further demonstrated in hormone-treated mice, where progesterone administration induced a diestrus-like state that resulted in elevated specific IgG-to-IgA ratios. Interestingly, unimmunized mice were only susceptible to intravaginal (ivag) infection with HSV-2 during diestrus. Mice immunized i.n. with AdgB8 and given progesterone were protected from a lethal intravaginal HSV-2 challenge, despite the fact that virus replication was present for 4 days postchallenge. Further, high numbers of gB-specific IgA and IgG antibody-secreting cells were present in both the genital tracts and the draining iliac lymph nodes of i.n.-immunized, but not unimmunized, mice 6 days following ivag HSV-2 challenge. These results demonstrate that the levels of specific antibodies in the female genital tract are dependent on the stage of the estrous cycle. Furthermore, i.n. AdgB8 immunization provided a significant level of protection and specific IgA and IgG antibodysecreting cells in the genital tissues during resolution of an ivag infection with HSV-2. ᭧
INTRODUCTION
of the murine genital tract is mainly a result of active transport by secretory component (SC) through the uterAntibodies in the mucosal secretions of the genital ine epithelium, whereas IgG found in cervicovaginal setract represent the first specific immune barrier against cretions is generally due to transudation through the vagthe penetration of sexually transmitted pathogens inal epithelium (Brandtzaeg et al., 1994; Mestecky, 1987; (Brandtzaeg et al., 1994; Mestecky, 1987; Mestecky et Mestecky et al., 1994; Parr, 1990, 1994a; Underal., 1994; Mogens and Russell, 1994) . Antibodies of both down and . The levels of SC and total IgG and IgA isotypes are present in genital secretions immunoglobulins in the female genital tract have been and both have been shown to be important in this protecreported to change over the course of the estrous cycle tion (Brunham et al., 1983; Eis-Hubinger et al., 1993; Mer-(Sullivan and Wira, 1983; Sandoe, 1977, 1980; riman et al., 1984; Mogens and Russell, 1994; Whaley et Wira et al., 1994) . In rodents, SC is present at its highest al., 1994). Secretory IgA is particularly well suited for levels in uterine fluids during proestrus and estrus (Sullimucosal surfaces due to its greater avidity and resis- van and Wira, 1983) . Since SC is responsible for delivtance to proteolytic cleavage (Magnusson and Stjernering IgA to the mucosal surface it is not surprising that strom, 1982; Mogens and Russell, 1994) . Although the total IgA levels in rat uterine secretions were significantly primary function of IgA has been regarded as the ability higher during estrus and proestrus when compared to to neutralize pathogens at the mucosal surface (Mogens diestrus Sandoe, 1977, 1980; Wira et al., 1994). and Russell, 1994) , more recently, in vitro (Mazanec et The levels of total IgG have also been shown to change al., 1992, 1995) and in vivo (Burns et al., 1996) models with the estrous cycle with the highest levels occurring have demonstrated that secretory IgA is capable of formduring proestrus Sandoe, 1977, 1980; Wira et ing intracellular complexes with viruses and inhibiting al., 1994) . The migration of lymphocytes into the genital virus replication and subsequently preventing primary or tract is also influenced by the estrous cycle since inresolving chronic infections.
creased numbers of IgA plasma cells are observed in The presence of secretory IgA at the mucosal surface genital tissues during proestrus and estrus (Canning and Billington, 1983; McDermott et al., 1980; Rachman et al., 1983) . These cyclic changes in SC and total antibody Sullivan et al., 1984; Suzuki et al., 1984; Usala et al., al., 1994; Milligan and Bernstein, 1995; . Recently we showed that intranasal (i.n.) immunization 1989), suggesting that the hormones that control the reproductive cycle are intimately involved in these with a recombinant adenovirus capable of expressing gB of HSV-1 (AdgB8) induced both gB-specific IgA and IgG changes. Indeed, progesterone and estrogen have been shown to be directly responsible for influencing the levels in vaginal washes of mice (Gallichan and Rosenthal, 1995) . In this study we examined the influence of the of SC and antibodies, as well as the numbers of B cells in the genital tract (Parr and Parr, 1994a; estrous cycle on the levels of HSV gB-specific IgA and IgG antibodies in the female genital tract following i.n. 1983; Wang et al., 1996; Sandoe, 1977, 1980; Wira et al., 1994) .
immunization with AdgB8. In addition, mice immunized intranasally with AdgB8 were challenged intravaginally As mentioned, the induction of specific antibodies in genital secretions is considered necessary for protection with HSV-2 and the subsequent pathology, viral replication, and B cell responses in the genital tissues were against infection with sexually transmitted pathogens such as herpes simplex virus (HSV) or HIV (Brandtzaeg evaluated. et al., 1994; Mestecky, 1987; Mestecky et al., 1994; Mogens and Russell, 1994) . In examining the induction of MATERIALS AND METHODS humoral immunity in the female genital tract, immunizaAnimals and cell cultures tion by systemic routes (sc, im, and ip) has been shown to induce specific antibodies in several species including Female C57Bl/6 (H-2 b ) mice used in immunization and humans (Bouvet et al., 1994; Gallichan and Rosenthal, challenge studies and in the evaluation of vaginal wash 1995; Miller et al., 1992; Nakao et al., 1994; Ogra and antibody levels were 6 to 8 weeks of age during primary Ogra, 1973; Parr and Parr, 1990; Thapar et al., 1990a,b) .
immunization and were obtained from Charles River LabAlthough high titers of specific IgG antibodies were inoratories (Constant, Quebec, Canada). Mouse colonies duced in these studies, the levels of specific IgA were were maintained on a 12-hr light/dark cycle. Vero and generally low or not reported. As a mucosal route of 293 cells were grown in a-MEM (GIBCO Laboratories, immunization, intravaginal (ivag) or intrauterine inoculaBurlington, Canada), supplemented with 10% fetal calf tion has been shown by some groups to induce both serum (FCS; GIBCO) and 1% penicillin-streptomycin and specific IgG and IgA antibodies in the genital tract (Milli-L-glutamine (GIBCO). 293-N2S cells are a nonadherent gan and Bernstein, 1995; Ogra and Ogra, 1973; cell line derived from 293 cells and were grown in spinner al., 1994). However, in many other studies the titers were flasks with Joklik's media supplemented as above. low or consisted mainly of IgG antibodies (Gallichan and Rosenthal, 1995; Lehner et al., 1992; Virus strains and inoculations 1990; Miller et al., 1992; The construction of the replication-competent recom-1988; Thapar et al., 1990a,b) , perhaps attributable to the binant adenovirus type 5 vector, AdgB8, was reported generalized lack of secondary lymphoid nodules in the elsewhere (Hutchinson et al., 1993) . Briefly, AdgB8 congenital tract . In contrast, immunizatains the gB gene from HSV-1 coupled to the SV40 protion at other mucosal sites (ig or i.n.) has been successful moter and inserted into the E3 region of human adenoviin generating specific IgG and IgA antibodies in the genirus type 5. Recombinant adenoviruses were grown in tal tract (Gallichan and Rosenthal, 1995; Lubeck et al., 293-N2S cells, purified twice on CsCl gradients, and ti-1994; Muster et al., 1995; Wu and Russell, 1993) . Few of tered on 293 cells. HSV-2 strain 333 was propagated and the studies concerned with specific antibodies in the titered on Vero cells. genital tract took into account the stage of the reproducFor AdgB8 immunization, mice were ether anesthetive cycle during sampling and evaluation of antibody tized, inverted, and inoculated i.n. with 10 8 PFU of AdgB8 titers.
by introducing virus in 10 ml of phosphate-buffered saline Herpes simplex virus type 2 is a sexually transmitted (PBS, pH 7.4) directly into the nares by means of a microagent that attaches, penetrates, and undergoes infecpipet. For ivag HSV-2 challenge, mice were first injected tious cycles of replication in the epithelium of the genital subcutaneously with 2 mg of progesterone/mouse tract. Most studies concerned with protection against (Depo-Provera; Upjohn, Don Mills, Ontario), and 5 days genital HSV-2 infection have focused on systemic immulater mice were anesthetized using halothane, swabbed nization (Bernstein et al., 1990; Burke et al., 1994 ; Byars ivag with a cotton applicator, placed on their backs, and et al., 1994; Heineman et al., 1995; Nakao et al., 1994;  infected intravaginally for 1 hr with 10 ml of HSV-2 while Straus et al., 1994) , despite the evidence supporting mubeing maintained under anesthetic. cosal immunization as the optimum route for the induction of both IgA and IgG antibodies in the genital tract.
Collection of fluids and estrus staging The exception to this involves ivag immunization with attenuated strains of HSV-2 that protected mice against
Vaginal fluid for estrus staging and antibody determinations was collected by pipetting 30 ml of PBS into and ivag HSV-2 challenge (McDermott et al., 1987; Mclean et out of the vagina several times. The staging of the estrous amined individually, as ratios of IgG divided by IgA, or as grouped percentages of maximum. Grouped percentcycle for each mouse was based on a smear from these washings (Allen, 1922) . Smears were stained with Diffages of maximum were determined by first converting the titers of anti-gB IgG and IgA into a percentage of Quik (Baxter Scientific Products, Miami, FL). By examining the cells present in the smears we were able to maximum by dividing the titer determined for each day by the maximum that we observed over the course of determine whether the animal was in estrus, metestrus, diestrus, or proestrus. The vaginal washings were then the two cycles for individual mice. In this way we were able to pool the percentages of maximums for each escentrifuged to remove particulate matter and the supernatants were stored at 020Њ for subsequent antibody trus stage from among several mice. determination.
Lymphocyte isolation Viral replication and pathology in the reproductive tract Single cell suspensions from lymph nodes were prepared by smashing the lymph nodes on a grid etched Following ivag HSV-2 inoculation, mice were sampled on plastic plates with an 18-gauge needle. To obtain daily for 6 days by pipetting 30 ml of PBS into and out of lymphocytes from the genital tract, the vagina, cervix, and the vagina followed by a swabbing with a cotton applicauterine horns were removed from groups of five mice, tor. Both the wash and the applicator were combined minced with scissors, and digested with an enzyme soluwith 0.97 ml of PBS and frozen at 070Њ. Viral titers were tion containing collagenase (0.5 U/ml, Boehringer Manndetermined by plaque assay on Vero cell monolayers. heim), Dispase II (1.2 U/ml, Boehringer Mannheim), and The dilution of each vaginal wash supernatant was conDNAse (5 U/ml, Calbiochem). Two successive digests sidered to be 10 02 .
were performed for 1 hr at 37ЊC. Lymphocytes were enGenital pathology was monitored daily following HSV-2 riched by passing the cell fractions over Ficoll gradients challenge and scoring was performed blinded. Pathology and then culturing for 2 hr to remove adherent epithelial was scored on a 5-point scale: 0, no apparent infection; and fibroblast cells. 1, slight redness of external vagina; 2, redness and swelling of external vagina; 3, severe redness and swelling of Antibody-secreting cell (ASC) enumeration by external vaginal and surrounding tissue; 4, genital ulcer-ELISPOT assay ation with severe redness, swelling and hair loss of genital and surrounding tissue; 5, severe genital ulceration Ninety-six-well filtration plates backed with nitrocelluextending to surrounding tissue. Mice were sacrificed lose membrane (Millipore Corp., Bedford, MA) were upon reaching stage 5. coated with 10 mg/ml recombinant HSV-2 gB (provided by R. L. Burke) or 1/500 dilution of goat anti-mouse IgG Antibody determination or IgA (Southern Biotechnology Associates) in PBS, and kept overnight at 4Њ. A PBS solution containing 10 mg/ Total and HSV gB-specific antibody titers were determined by ELISAs performed in flat-bottomed microtiter ml bovine serum albumin, pH 7.4, was used to block any nitrocellulose not precoated with antibody or gB protein. plates (Costar, Cambridge, MA). Plates were precoated with 2.5 mg/ml recombinant HSV-2 gB (kindly provided Serially diluted single cell suspensions of iliac lymph nodes or genital tract digests plus supplemented RPMI by R. L. Burke, Chiron, Emeryville, CA) for gB-specific antibody titers, and 1/1000 dilution of goat anti-mouse media (10% FCS) were plated at 37Њ for 16 hr. The number of plasma cells in each preparation secreting total or IgG or IgA (Southern Biotechnology Associates, Birmingham, AL) for total antibody titers, in borate-buffered HSV gB-specific IgA or IgG antibody was determined by washing each well with PBS-Tween 20 to remove cells saline, pH 8.5, and kept overnight at 4Њ. A Tris-buffered saline solution containing 10 mg/ml bovine serum albuand developing the plate by the addition of biotinylated goat anti-mouse IgA or anti-IgG (Southern Biotechnology min, pH 7.4, was used to block any plastic not precoated with antibody or gB protein. Serially diluted samples of Associates), followed by avidin-peroxidase. Spots representing individual antibody-secreting cells were visualhyperimmune control, test sera, or sample supernatants were added, followed by either biotin-labeled goat antiized by developing with peroxidase substrate containing H 2 O 2 and 3-amino-9-ethylcarboazole in acetate buffer. mouse IgG or IgA antibody (Southern Biotechnology Associates, Birmingham, AL). The labeling reagent was alSpots were enumerated by digitized image analysis and discrimination from background was based on gray denkaline phosphate (ExtrAvidin; Sigma, St. Louis) and the ELISA amplification system (GIBCO, Burlington, Ontario) sity and then size (program written by Dr. L. Arsenault, Microscopy Group, McMaster University, Hamilton, Onwas used as a substrate. Antibody titers represent the inverse dilution of the sample at which two times the tario). Counts were visually confirmed in case of overlapping spots. Results are expressed as the mean number background absorbance of control or lavage fluid from uninfected mice was reached. Antibody levels were exof ASC per million mononuclear cells for each tissue.
Statistical analysis
Data were analyzed using the GraphPAD InStat program (GraphPAD Software, San Diego, CA). For comparisons between two groups, data were analyzed by Student's t test or Fisher's exact test as appropriate. Comparison among the means of multiple groups was carried out using analysis of variance.
RESULTS

Variation in specific vaginal wash antibody levels during the estrous cycle
In our previous studies we observed the presence of specific antibodies to gB of HSV-1 in the vaginal washes of mice immunized i.n. with AdgB8 (Gallichan and Rosenthal, 1995) . The levels of these antibodies tended to vary greatly between mice and within individual mice over time. Since immunoglobulin levels are influenced by the estrous cycle, we determined the titers of HSV gB-specific IgG and IgA in vaginal washes on a daily basis and correlated them with the stage of the estrous cycle. Figure 1A shows data from a representative mouse immunized 6 weeks previously with AdgB8 and sampled daily over two estrous cycles. The absolute titers of gB-specific antibodies in this mouse demonstrated that, indeed, there was a large variation from day to day. Moreover, there appeared to be a cyclic fluctuation in the titers of gB-specific IgG and IgA that varied with the stage of the cles and expressed as percentages of maximums to accommodate the varying magnitudes of specific antibodies observed. In Fig. 2A it is clear that the levels of antigB IgA and IgG fluctuated with the estrous cycle. In fact, Figure 1B demonstrates that the gB-specific IgG-to-IgA the levels of anti-gB IgA during estrus were significantly ratios from the vaginal washes of the mouse in Fig. 1A higher than those observed during diestrus or proestrus followed a cyclic pattern and were highest during dies-(P £ 0.05). In contrast, the levels of anti-gB IgG observed trus and lowest during estrus. In addition, there was as during diestrus were significantly higher than during esmuch as a 93-fold difference in ratios between estrus trus (P £ 0.001) (Fig. 2A) . This inverse relationship beand diestrus. These cyclic trends were similar in all mice tween isotype expression indicates that over the course that we examined. To examine a group of mice, the ratios of the estrous cycle specific IgA levels are highest during of anti-gB IgG to IgA from four mice were pooled (over periods of estrus and lowest during diestrus, whereas two cycles each) from each of the four estrous stages specific IgG levels are highest during periods of diestrus by first normalizing the ratios in each mouse to a scale and lowest during estrus. The levels of specific IgA and of 1.0. The ratios in Fig. 2B demonstrate that the relative IgG during metestrus and proestrus lie in between. levels of gB-specific IgG compared to IgA were significantly higher during diestrus compared to all other Ratios of specific IgG-to-IgA antibodies in vaginal stages (P £ 0.001). In addition, the ratio at diestrus was washes 15 times greater than during estrus, and conversely, during estrus the levels of specific IgA were relatively much The relationship between the levels of specific IgG relative to IgA was examined at each stage of the estrous higher than IgG. The inverse relationship between levels of gB-specific IgG and IgA at each stage of estrous was cycle by determining the ratios of gB-specific IgG to IgA. observed in the vaginal washes of mice infected during diestrus or late metestrus. There was no virus replication observed in mice infected at estrus. The results presented in Table 1 are representative of several experiments examining a number of animals at each stage. Interestingly, the dose of HSV-2 used for infection represents more than a 1000-fold lethal dose (unpublished data). Thus mice appeared to be highly resistant to intravaginal HSV-2 infection at estrus. The stages of the estrous cycle occurring on days subsequent to infection did not seem to influence the amount of virus recovered in vaginal washes (data not shown). By Day 6 the mice that were infected during diestrus or late metestrus had developed moderate to severe pathology of the exterior genital tissues. In contrast, mice infected during estrus displayed no genital pathology.
To examine the site and extent of tissues infected, the uterus, vagina (including the cervix), and nerves innervating the genital tissues were isolated. Only the tissues from mice infected during diestrus or late metestrus contained virus (Table 1 ). The level of infection in vaginal tissues was severalfold higher than in the uterus of all mice we examined, indicating that the primary site of HSV-2 infection following intravaginal inoculation is in the vagina. Virus was also observed in the nerves of severely infected animals. These results indicate that mice are primarily susceptible to HSV-2 infection during early to late periods of diestrus and that the primary site of infection is in the vagina, with further infection of the intranasally with AdgB8. The stages of the estrous cycle were determined daily by cytology from a smear of the vaginal washes of a group of four mice each examined daily over two estrous cycles. Estrus (E), Influence of progesterone on specific antibody ratios n Å 16; metestrus (M), n Å 9; diestrus (D), n Å 8; proestrus (P), n Å in vaginal washes 5. (A) The titers of gB-specific IgA (hatched bars) and IgG (solid bars) in each mouse were expressed as a percentage of maximum observed Administration of progesterone induces mice into a over the two cycles and then grouped between and within mice acdiestrus-like state and is known to make mice highly cording to the stage of the estrous cycle. HSV gB-specific IgG during susceptible to intravaginal infection with HSV (Parr et al., diestrus was significantly greater than during estrus, P £ 0.001; HSV 1994). To determine the influence of this treatment on gB-specific IgA during estrus was significantly greater than during diesspecific antibody levels in the genital tract we examined trus or proestrus, P £ 0.05. (B) The ratios of HSV gB-specific IgG to IgA for each day over two estrous cycles for each of the four mice in the ratios of vaginal wash anti-gB IgG to IgA in six mice A were normalized to a scale of 1 and then grouped together. Anti-gB that were immunized intranasally with AdgB8. By Day 3
IgG to IgA during diestrus was significantly greater than during the the ratios had increased dramatically and were signifiother three stages, P £ 0.001. cantly greater than the preceding days (P õ 0.05) (Fig.  3 ). In addition, by Day 3 post-hormone treatment all six mice had entered a diestrus-like state which was mainalso observed for total antibodies in vaginal washes tained for more than a week. During this diestrus-like (data not shown).
state the titers of gB-specific IgA antibodies were exInfluence of the estrous cycle on susceptibility to tremely low or undetectable.
HSV-2 infection
Intranasal immunization protects against intravaginal To examine the influence of the estrous cycle on sus-HSV-2 infection ceptibility to ivag HSV-2 infection, unimmunized mice were infected at various estrous stages and monitored
Next we determined whether mice immunized intranasally with AdgB8 were protected from ivag HSV-2 infecfor virus replication by examining vaginal fluids daily and tissues on Day 6 after infection. Table 1 demonstrates tion during a progesterone-induced diestrus-like state.
Five days following progesterone treatment, control (unthat over the 6 days examined, virus replication was only b On the 6th day following infection tissues were isolated and homogenized, and viral titers were determined. c Estrous staging was determined histologically: estrus (E), metestrus (M), diestrus (D), proestrus (P).
immunized) and immunized mice were inoculated ivag was also significantly reduced in the i.n.-immunized mice over the 6 days (P õ 0.0001). Of the 14 AdgB8-immunized with a lethal dose of HSV-2 (Table 2 ). Subsequent daily evaluation of genital pathology, survival, and virus replimice, 5 were completely protected from any discernable genital pathology. Interestingly, these 5 mice were cation in vaginal washes of control and immunized animals was determined in a blinded fashion. All of the among the mice that had cleared any signs of viral replication by Day 5. The remaining 9 mice all developed control animals were infected with virus and demonstrated genital pathology by Day 4, eventually sucgenital pathology; however, 4 of these mice displayed only minor symptoms (pathology score £ 3), and subsecumbing to infection on Day 6 (having reached a genital pathology score of 5). In contrast, mice immunized i.n. quently cleared the infection by Day 7 and any signs of pathology by Day 12. Therefore, a significant number of with AdgB8 demonstrated a significant level of protection against HSV-2 infection. Although virus replication was immunized mice (9 of the 14) survived past acute infection (P õ 0.005). observed in the genital tracts of all the immunized mice for the first 4 days postinfection, by Day 5, virus was Detection of specific antibody-secreting cells in the isolated from only 8 of the immunized mice (P £ 0.01).
genital tract In addition, by Day 5 there was a significant decrease in viral replication in the 6 remaining immunized mice (P The presence of ASC specific for gB of HSV-2 was õ 0.0001). The severity of infection or genital pathology examined in the genital tracts and iliac lymph nodes (ILN) of immunized and control mice following an ivag HSV-2 challenge. High numbers of gB-specific IgA and IgG ASC were present in both the genital tracts and the draining ILN of i.n.-immunized mice 6 days following ivag HSV-2 challenge (Table 3 ). The gB-specific ASC observed in the ILN represented 65 and 35% of the total IgA and IgG ASC present, respectively. In the genital tracts they represented 8 and 92% of the total IgA and IgG ASC present, respectively. This is in contrast to control animals in which no gB-specific ASC were observed in the genital tissues and only a small number of IgG ASC were observed in the ILN. The IgG ASC present in the ILN of control animals likely represents the development of a primary response and consisted of only 2% of the total IgG ASC present (and was 19 times less than that ob- The capability of the female genital tract to maintain wash and then normalized to a scale of 1 for each mouse prior to grouping. Day 3 was significantly greater than Day 0, P £ 0.05 (*).
a high level of sterility and at the same time provide an Significance between AdgB8-immunized and unimmunized mice: *P õ 0.0001; **P õ 0.005; ***P õ 0.01.; ****P õ 0.025. a Mice were intravaginally challenged with 2 1 10 4 PFU of HSV-2; immunized mice were innoculated with AdgB8 3 weeks previously. b Number of mice in which virus was detected/total. c Mean { SD log 10 PFU; calculated using only animals that experienced viral replication. d Mean { SD; measured as area under the lesion score-day curve for first 6 days. e Number of mice with that demonstrated no overt genital pathology/total (i.e., score of 0). f Number of mice surviving infection/total. environment suitable for conception requires the coordimurine genital tract and, anatomically, IgA originates mainly from the uterus/endocervix and IgG from the vanation of a large number of specific and nonspecific factors. The main specific factors that contribute to protecgina (Mestecky, 1987; Parr, 1990, 1994; Wira et al., 1994) . In our previous investigations, we demontion in the genital tract include the effector functions of humoral-and cell-mediated immunity (Brandtzaeg et al., strated that i.n. immunization with a recombinant adenovirus vector capable of expressing gB of HSV-1 (AdgB8) 1994; Mestecky et al., 1994; Tristram and Ogra, 1994; Underdown and Mestecky, 1994) . Ininduced both IgA and IgG specific for gB in the genital tract (Gallichan and Rosenthal, 1995) . The current study deed, both arms of the immune system have been shown to be important for resistance to various pathogens that demonstrates that the levels of specific IgG and IgA antibodies in the genital tract of intranasally immunized mice infect the female genital tract (Brunham et al., 1983; EisHubinger et al., 1993; McDermott et al., 1987 McDermott et al., , 1989 McDermott et al., , 1990  vary inversely with each other and are dependent on the stage of the estrous cycle. Indeed, specific IgA titers Merriman et al., 1984; Whaley et al., 1994) . Arguably, humoral immunity or antibodies are the were higher during estrus than diestrus and specific IgG titers were higher during diestrus than estrus. This was first specific barrier encountered by sexually transmitted pathogens (Brandtzaeg et al., 1994; Mestecky, 1987;  further demonstrated in hormone-treated mice where progesterone administration induced a diestrus-like Mestecky et al., 1994; Underdown and Mestecky, 1994) . Both IgA and IgG are present in secretions from the state that resulted in elevated specific IgG-to-IgA ratios. In fact, while specific IgG titers reached their highest levels, specific IgA titers were extremely low to undetect- we detected are similar to those reported for total (Parr, tranasally Immunized Mice 6 Days Following Intravaginal HSV-2 Chal-1994; Sullivan et al., 1984; Wang et al., 1996; Wira et al., lenge 1994 ) and specific (Wira and Sandoe, 1980) is subjected to numerous pathogens  Unimmunized õ1 õ1 95.0 { 56.5 1.6 Profet, 1993; Tristram and Ogra, 1994 reproductive tract (Profet, 1993 present during this period to deal with the increased pathogen load associated with mating. Indeed, antibodto influence virus replication. The difference in thickness and permeability of the vaginal epithelium, as well as ies can be found in the uterine lumen bound to bacteria shortly after mating (Parr and Parr, 1985) . There may availability of viral receptors, during these periods may be responsible (Allen, 1922; . be two hormonally controlled factors that contribute to increased IgA levels during estrus. First, there is an inTo examine immunity in the genital tract within the environment of increased viral susceptibility (but decreased migration of plasma cells to the genital tract resulting in a greater number of IgA plasma cells during creased IgA levels) animals were induced into a diestruslike state by progesterone treatment prior to intravaginal proestrus and estrus (McDermott et al., 1980; Rachman et al., 1983) . Second, there is an increase in production HSV-2 challenge. Our results demonstrate that while none of the control animals survived infection, a signifiof SC in the uterine epithelium that fluctuates with the estrous cycle and is associated with estradiol adminiscant number of mice immunized intranasally with AdgB8 did survive (Table 2 ). Subsequent studies showed that tration Wira et al., 1994) . Interestingly, exogenous estradiol and progesterone influence intranasally immunized mice infected with a lower but still lethal dose of virus were completely protected from the levels of total IgA or IgG in the genital tract as well as both of the above phenomena, suggesting that the mortality as well as genital pathology (W. S. Gallichan and K. L. Rosenthal, manuscript in preparation). Of interincreased IgA levels observed during estrus are directly a result of the fluctuating hormone levels that occur over est was the fact that although gB-specific antibodies (mainly IgG) were present at the time of infection in imthe course of the estrous cycle (Wang et al., 1996; Wira et al., 1994; Wira and Sandoe, 1980) . munized animals, sterile immunity was not observed and the viral replication that occurred over the first 4 days The factors contributing to the relative decrease in IgG during estrus are likely due in part to architecture postinfection was similar to that occurring in control mice. In addition, while some immunized mice developed changes in the epithelium of the vagina. IgG originates mainly from serum transudation through the vagina and genital pathology, several of these completely cleared the primary infection and lacked any genital morbidity by the vaginal epithelium is known to undergo changes from a thin (3 to 7 layers) stratified epithelium at diestrus to a Day 12. These results suggest that the induction of specific anamnestic responses and not neutralization by muthick (12 to 13 layers) keratinized epithelium with a clearly defined basement membrane at estrus (Allen, 1922; cosal IgG antibodies present during initial infection were responsible for subsequent protection. In examining the and . These changes are also influenced by hormones with estrogen-dominated and progesteroneimmune mechanisms present during the period of viral clearance, we observed that the draining ILN and the dominated vaginal epithelium being similar to that of estrus and diestrus, respectively . The genital tissues of immunized but not control mice contained a large percentage of ASC specific for gB of HSVphysical structure of the vaginal epithelium, which is thinner during diestrus, also explains the increase in specific 2. Both IgG-and IgA-secreting plasma cells were present demonstrating that intranasal immunization induced IgG that we observed during this stage and which is likely due to increased serum transudation. In fact, promemory lymphocytes of both isotypes that were capable of responding to infection and entering the genital tract. teins can penetrate the vaginal epithelium during diestrus and IgG has been localized in the intercellular Interestingly, the gB-specific ASC in both the ILN and the genital tissues represented a large percentage of the spaces during this period . It would thus appear that the results presented here reflect the total ASC present; however, the gB-specific IgA ASC in the genital tissues were not as highly represented (Table ability of the genital tract to compensate for the decrease in protective IgG during estrus by actively recruiting IgA 3). This may be due to the progesterone-dominated environment since it has been observed that the circulation plasma cells and transporting IgA via SC into the uterine lumen.
of IgA plasma cells into the genital tissues decreases during diestrus (McDermott et al., 1980) . Nevertheless, The physical changes that occur in the vagina during the transition from diestrus to estrus are likely in preparagB-specific IgA ASC were present in the genital tissues during the resolution phase of infection and were more tion for mating and the increased pathogen load associated with this activity. Our data clearly show that unimmunumerous than the HSV-2-specific ASC reported in similar experiments where mice were protected from a lethal nized mice were susceptible to intravaginal HSV-2 infection during diestrus but not during estrus. Indeed, even HSV-2 challenge following intravaginal immunization with an attenuated HSV-2 virus (Milligan and Bernstein, at 1000-fold lethal dose mice were resistant to ivag infection during estrus. Thus our findings confirm those origi-1995). Interestingly, Eis-Hubinger et al. (1993) demonstrated that administration of gB-specific monoclonal annally made by Tepee et al. (1990) and . Following infection at diestrus, the stage of the estrous tibodies resulted in the rapid clearance of virus from the genital tracts of mice that had an established HSVcycle did not affect the level of virus recovered in vaginal washes. In other words, once infection was established 1 infection. Moreover, recent studies have revealed that in addition to neutralization at the mucosal surface, sesubsequent stages of the estrous cycle did not appear
